期刊文献+

腹腔镜胆囊切除术患者不同剂量舒芬太尼对术后恢复质量的影响 被引量:4

Effect of different doses of sufentanil on postoperative recovery quality in patients undergoing laparoscopic cholecystectomy
下载PDF
导出
摘要 ①目的观察腹腔镜胆囊切除术患者不同剂量舒芬太尼对术后恢复质量的影响。②方法选择择期腹腔镜胆囊切除术患者80例,随机分为4组(每组20例):等容量0.9%氯化钠组(对照组,Ⅰ组)、舒芬太尼0.1μg/kg(Ⅱa组)、0.2μg/kg(Ⅱb组)、0.3μg/kg(ⅡC组),所有患者采用靶控输注丙泊酚、瑞芬太尼和阿曲库按的麻醉方法,常规监测心电图、血压、心率、脉搏血氧饱和度、呼气末二氧化碳分压和脑电双频谱指数。在手术结束前10min分别于Ⅰ组、Ⅱa、b、c组静注等剂量的0.9%氯化钠和舒芬太尼0.1、0.3、0.5μg/kg。记录手术结束后患者自主呼吸恢复时间、苏醒时间和拔管时间,以及拔管后10min的视觉模拟疼痛评分(VAS评分)、舒适度评分(BCS评分)、镇静度(Ramsay)评分。③结果与Ⅰ组相比,Ⅱa和Ⅱb组的呼吸恢复时间、苏醒时间和拔管时间没有明显变化(P>0.05),但Ⅱc组的上述指标明显延长(P<0.05);Ⅱ(a,b,c)组的VAS评分、BCS评分和Ramsay评分差异有统计学意义(P<0.05)。④结论丙泊酚复合瑞芬太尼静脉麻醉下行腹腔镜胆囊切除手术结束前10min给予舒芬太尼0.2μg/kg可有效地缓解急性疼痛,对自主呼吸恢复和意识恢复没有明显影响。 Objective To study effect of different doses of sufentanil on postoperative recovery quality in patients undergoing laparoscopic cholecystectomy (LC) in remifentanil - based anesthesia with propofol. Methods 80 ASA Ⅰ or Ⅱ grade patients un-dergoing LC were randomly divided into 4 groups : control group ( Ⅰ group, NS) and sufentanil 0.1 μg/kg group ( Ⅱa group) ,0.2μg/ kg group( Ⅱb group) and 0.3μg/kg group( Ⅱ c group) (n = 20, in each group). ECG,BP,HR,PETCO2 and Bis were monitored during operation. Anesthesia was induced and maintained with propofol and remifentanil by TCI in all patients, which received intra-venous instillation of 2mL NS and sufentanil (1 μg/kg, 2μg/kg and 3 μg/kg)10 min before the end of the operation respectively. Propofol and remifentanil was switched off 10 min before the end of surgery. Time of spontaneous respiraory resumption ,eye opening time and extubation time were measured, VAS,BCS and Ramsay scale were evaluated. Results Compared with I group,there were no significant differences in the time of spontaneous respiratory resumption, eye opening time and extubation time between I group to Ⅱb group( P 〉 0.05 ) , but above targets in Ⅱ c group lengthen obviously( P 〈 0.05 ) , there were significant differences in VAS, BCS and Ramsay scale between Ⅱ a to Ⅱ c groups ( P 〈 0.05 ). Conclusion Administration of sufentanil (0.2 μg/kg) 10 min be-fore the end of LC can effectively provide pain relief, there was no obvious effects on time of spontaneous respiratory resumption, eye opening and extubation.
出处 《河北联合大学学报(医学版)》 2013年第1期8-10,共3页 Journal of North China Coal Medical College
基金 唐山市新药与临床医学研究计划(No.07130206A-4-7)
关键词 舒芬太尼 腹腔镜 胆囊切除术 视觉模拟疼痛评分 舒适度评分 RAMSAY评分 Sufentanil Laparoscope Cholecystectomy VAS BCS Ramsay scale
  • 相关文献

参考文献9

  • 1丘少鹏,郑克立,吴志棉,谭敏,赵振献,郑朝旭.后腹腔镜手术在泌尿外科的应用[J].中国内镜杂志,1998,4(5):18-19. 被引量:37
  • 2Roth - Isigkeit A, Brechmann J,Dibbeh L,et al. Persistent endocrine stress response in patients undergoing cardiac surgery[ J ]. J Endocrinol Invest, 1998,21 ( 1 ) : 12.
  • 3Ahonen J, Olkkola KT, Hynynen M, et al. Comparison of alfentanil, fen- tanyl and sufentanil for total intlavenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery[ J]. Br J Anaesth, 2000,85(4) :533.
  • 4Thomson IR, Harding G, Hudson tkl. A comparison of fentanyl and sufentanil in patients undergoing coronary artery bypass graft surgery [ J ]. J C ardiothorac Vasc Anesth ,2000,14 (6) :652.
  • 5史春霞,李立环,卿恩明,姜贞,李士通,姚尚龙,郭曲练,王文贤,熊利泽,张铁铮,齐娟,付志俭.舒芬太尼麻醉用于心血管手术的多中心临床研究[J].临床麻醉学杂志,2005,21(8):519-521. 被引量:114
  • 6赵建明,刘建芳,梁军成.瑞芬太尼临床的应用[J].中国临床药理学杂志,2008,24(4):368-369. 被引量:54
  • 7王春光,瞿慧,艾青,张志捷,段满林,徐建国.舒芬太尼、曲马多对雷米芬太尼苏醒期躁动的预防效应[J].临床麻醉学杂志,2007,23(11):897-900. 被引量:92
  • 8Bailey PL, Streisand JB, East KA, et al. Difference in magnitude and duration and opiond - induced respiratory depression and analgesia with fentanyl and sufentanil [ J ]. Anesth Analg, 1990,70 ( 1 ) :8.
  • 9Youngs E J, Shafer SL. Pharmacokinetic parameters relevant to recovery from opioids [ J]. Anesthesiology, 1994,81 (4) :833.

二级参考文献28

  • 1James MK,Feldman PL,Schuster SV. et al. Opioid receptor activety of GI 87084B, a novel ultra- short acting analgesic, in isolated tissues [J]. J Pharmacol Exp Ther,1991 ;259:713 -718.
  • 2Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal [ J ]. Clin pharmacokinet, 1995 ; 29 : 80 - 94.
  • 3Egan TD. Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000 [J]. Curt Opin Anaesth,2000; 13:449 - 455.
  • 4Patel SS, Spencer CM. Remifentanil[J]. Drugs, 1996; 52: 417- 427.
  • 5Shinohara K, Aono Hunruh GK. Suppressive effects of remifentanil on hemondynamic in baro- denervated rabbits[ J ]. Can J Anaesth, 2000; 47 : 361 - 366.
  • 6Lang E, kapila A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil [ J ]. Anesthesiology, 1996 ; 85 : 721 - 728.
  • 7Michelsen LG, Hug Jr CC. The pharmacokinetics remifentanil [ J ]. J Clin Anesth, 1996 ; 8 : 679 - 682.
  • 8Westmoreland C, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI 87084B) and its major metabolite( GI 90291 ) in patients undergoing elective inpatients surgery [ J ]. Anesthesiology, 1993; 79:893 - 903.
  • 9Bouillon T, Bruhn J, Radu - Radulescu L, et al. Non - steady state analysis of the pharmacokinetic interaction between propofol and remifentanil[ J]. Anesthesiology, 2002 ; 97 : 1350 - 1362.
  • 10Scott LJ, Perry CM. Remifentanil. A review of its use during the inducting and maintence of general anaesthesia [ J ]. Drugs, 2005 ; 65 : 1793 - 1823.

共引文献292

同被引文献22

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部